Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Envoy Medical, Inc. - Class A Common Stock (NQ: COCH )

2.180 -0.020 (-0.91%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 52,197
Open 2.160
Bid (Size) 2.080 (2)
Ask (Size) 2.240 (2)
Prev. Close 2.200
Today's Range 2.080 - 2.320
52wk Range 1.010 - 11.46
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication
From Envoy Medical, Inc
Via GlobeNewswire

Performance

YTD
+15.34%
+15.34%
1 Month
-13.15%
-13.15%
3 Month
-26.60%
-26.60%
6 Month
-16.79%
-16.79%
1 Year
+77.24%
+77.24%

More News

Read More
Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System
From Envoy Medical, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device
From Envoy Medical, Inc
Via GlobeNewswire
Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare Coverage
From Envoy Medical, Inc
Via GlobeNewswire
Envoy Medical to Present at the LD Micro Main Event XVII
From Envoy Medical, Inc
Via GlobeNewswire
American Medical Association Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical’s Esteem® Device
From Envoy Medical, Inc
Via GlobeNewswire
Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market
From Envoy Medical, Inc
Via GlobeNewswire
Major Envoy Medical Investor Glen Taylor Discusses How Apple’s AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company
From Envoy Medical, Inc
Via GlobeNewswire
Envoy Medical Awarded Patent for Recharge System used with Implantable Battery
From Envoy Medical, Inc
Via GlobeNewswire
Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying
Via Benzinga
Envoy Medical Secures Lending Facility of $10M
From Envoy Medical, Inc
Via GlobeNewswire
COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage
From Envoy Medical, Inc
Via GlobeNewswire
Envoy Medical Announces Inclusion in the Russell Microcap Index
From Envoy Medical, Inc
Via GlobeNewswire
Envoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Directors to Prepare for Scaling
From Envoy Medical, Inc
Via GlobeNewswire
Envoy Medical Announces Inclusion in the MSCI USA Micro Cap Index
From Envoy Medical, Inc
Via GlobeNewswire
Newly Published Peer-Reviewed Article Highlights Advances in Fully Implanted Cochlear Implant Technology
From Envoy Medical, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Envoy Medical to Present at the Planet MicroCap Showcase: Vegas 2024
From Envoy Medical, Inc
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.